Dendrimers and the development of new complex nanomaterials for biomedical applications

Current Medicinal Chemistry

Volumn 19, Issue 29, 2012, Pages 4913-4928

  Gardikis, K ^a,b   Micha Screttas, M ^a   Demetzos, C ^b   Steele, B R ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Carbon nanotubes; Dendrimer chemistry; Drug delivery; Hyperbranched polymers; Imaging; Liposomes; Multifunctional dendrimers; Nanocarriers; Nanocomplexes; Nanoparticles; Quantum dots

Indexed keywords

CONTRAST MEDIUM; DENDRIMER; LIPOSOME; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; NANOTUBE; QUANTUM DOT;

DRUG DELIVERY SYSTEM; HUMAN; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; SYNTHESIS; ZETA POTENTIAL;

ANIMALS; BIOMEDICAL TECHNOLOGY; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOTECHNOLOGY;

EID: 84870414034     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311209024913     Document Type: Review

References (208)

1. Mitra, A.; Nan, A.; Line, B. R.; Ghandehari, H. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr. Pharm. Des., 2006, 12, 4729-4749.
2. Ding, B. S.; Dziubla, T.; Shuvaev, V. V.; Muro, S.; Muzykantov, V. R. Advanced drug delivery systems that target the vascular endothelium. Mol. Interv., 2006, 6, 98-112.
3. Klajnert, B.; Bryszewska, M. Dendrimers in Medicine; Nova Science Pub Inc, 2007; p. 141.
4. Foldvari, M.; Bagonluri, M. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomed.-Nanotechnol., 2008, 4, 183-200.
5. McBain, S. C.; Yiu, H. H. P.; Dobson, J. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed., 2008, 3, 169-180.
6. Mozafari, M. R.; Pardakhty, A.; Azarmi, S.; Jazayeri, J. A.; Nokhodchi, A.; Omri, A. Role of nanocarrier systems in cancer nanotherapy. J. Liposome Res., 2009, 19, 310-321.
7. Doshi, N.; Mitragotri, S. Designer biomaterials for nanomedicine. Adv. Funct. Mater., 2009, 19, 3843-3854.
8. Raemdonck, K.; Demeester, J.; De Smedt, S. Advanced nanogel engineering for drug delivery. Soft Matter, 2009, 5, 707-715.
9. Losic, D.; Simovic, S. Self-ordered nanopore and nanotube platforms for drug delivery applications. Expert Opin. Drug. Deliv., 2009, 6, 1363-1381.
10. Stromme, M.; Brohede, U.; Atluri, R.; Garcia-Bennett, A. E. Mesoporous silica-based nanomaterials for drug delivery: Evaluation of structural properties associated with release rate. WIREs Nanomed. Nanobiotechnol., 2009, 1, 140-148.
11. Dhankhar, R.; Vyas, S. P.; Jain, A. K.; Arora, S.; Rath, G.; Goyal, A. K. Advances in novel drug delivery strategies for breast cancer therapy. Artif. Cell. Blood Substit. Biotechnol., 2010, 38, 230-249.
12. Lebhardt, T.; Roesler, S.; Beck-Broichsitter, M.; Kissel, T. Polymeric nanocarriers for drug delivery to the lung. J. Drug Deliv. Sci. Technol., 2010, 20, 171-180.
13. Zablotskaya, A.; Segal, I.; Lukevics, E. Iron oxide-based magnetic nanostructures bearing cytotoxic organosilicon molecules for drug delivery and therapy. Appl. Organomet. Chem., 2010, 24, 150-157.
14. Cai, Z.; Wang, Y.; Zhu, L. J.; Liu, Z. Q. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr. Drug Metab., 2010, 11, 197-207.
15. Brewer, E.; Coleman, J.; Lowman, A. Emerging technologies of polymeric nanoparticles in cancer drug delivery. J. Nanomater., 2011, 2011, 1-10.
16. Beg, S.; Rizwan, M.; Sheikh, A. M.; Hasnain, M. S.; Anwer, K.; Kohli, K. Advancement in carbon nanotubes: Basics, biomedical applications and toxicity. J. Pharm. Pharmacol., 2011, 63, 141-63.
17. Rosenholm, J. M.; Sahlgren, C.; Linden, M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr. Drug Targets, 2011, 12, 1166-1186.
18. Wang, Y. Q.; Chen, L. X. Quantum dots, lighting up the research and development of nanomedicine. Nanomed.-Nanotechnol., 2011, 7, 385-402.
19. Pinheiro, M.; Lúcio, M.; Lima, J. L. F. C.; Reis, S. Liposomes as drug delivery systems for the treatment of TB. Nanomedicine, 2011, 6, 1413-28.
20. Doane, T. L.; Burda, C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev., 2012, 41, 2885-2911.
21. Maeda, H.; Bharate, G. Y.; Daruwalla, J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm., 2009, 71, 409-419.
22. Torchilin, V. P. Multifunctional nanocarriers. Adv. Drug Delivery Rev., 2006, 58, 1532-1555.
23. Torchilin, V. P. Multifunctional Pharmaceutical Nanocarriers; Springer: New York, NY, 2008; Vol. 4.
24. Paleos, C. M.; Tsiourvas, D.; Sideratou, Z.; Tziveleka, L. Multifunctional dendritic drug delivery systems: Design, synthesis, controlled and triggered release. Curr. Top. Med. Chem., 2008, 8, 1204-1224.
25. Shi, D. L. Integrated multifunctional nanosystems for medical diagnosis and treatment. Adv. Funct. Mater., 2009, 19, 3356-3373.
26. Fernandez-Fernandez, A.; Manchanda, R.; McGoron, A. J. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl. Biochem. Biotechnol., 2011, 165, 1628-1651.
27. Kono, K.; Nakashima, S.; Kokuryo, D.; Aoki, I.; Shimomoto, H.; Aoshima, S.; Maruyama, K.; Yuba, E.; Kojima, C.; Harada, A.; Ishizaka, Y. Multifunctional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapy. Biomaterials, 2011, 32, 1387-1395.
28. Mout, R.; Moyano, D. F.; Rana, S.; Rotello, V. M. Surface functionalization of nanoparticles for nanomedicine. Chem. Soc. Rev., 2012, 41, 2539-2544.
29. Jain, T. K.; Morales, M. A.; Sahoo, S. K.; Leslie-Pelecky, D. L.; Labhasetwar, V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm., 2005, 2, 194-205.
30. Nasongkla, N.; Bey, E.; Ren, J. M.; Ai, H.; Khemtong, C.; Guthi, J. S.; Chin, S. F.; Sherry, A. D.; Boothman, D. A.; Gao, J. M. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett., 2006, 6, 2427-2430.
31. Park, J. H.; von Maltzahn, G.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew. Chem., Int. Ed., 2008, 47, 7284-7288.
32. Delehanty, J. B.; Boeneman, K.; Bradburne, C. E.; Robertson, K.; Medintz, I. L. Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery. Expert Opin. Drug. Deliv., 2009, 6, 1091-1112.
33. Bardhan, R.; Chen, W.; Perez-Torres, C.; Bartels, M.; Huschka, R. M.; Zhao, L. L.; Morosan, E.; Pautler, R. G.; Joshi, A.; Halas, N. J. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv. Funct. Mater., 2009, 19, 3901-3909.
34. Zrazhevskiy, P.; Sena, M.; Gao, X. H. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem. Soc. Rev., 2010, 39, 4326-4354.
35. Wang, J. Y.; Wu, Q. F.; Li, J. P.; Ren, Q. S.; Wang, Y. L.; Liu, X. M. Photo-Sensitive Liposomes: Chemistry and Application in Drug Delivery. Mini-Rev. Med. Chem., 2010, 10, 172-181.
36. Arias, J. L. Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging. Expert Opin. Drug. Deliv., 2011, 8, 1589-608.
37. Koo, H.; Huh, M. S.; Sun, I.-C.; Yuk, S. H.; Choi, K.; Kim, K.; Kwon, I. C. In vivo targeted delivery of nanoparticles for theranosis. Acc. Chem. Res., 2011, 44, 1018-1028.
38. Lammers, T.; Aime, S.; Hennink, W. E.; Storm, G.; Kiessling, F. Theranostic nanomedicine. Acc. Chem. Res., 2011, 44, 1029-1038.
39. Dubertret, B.; Skourides, P.; Norris, D. J.; Noireaux, V.; Brivanlou, A. H.; Libchaber, A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science, 2002, 298, 1759-1762.
40. Wang, D. S.; He, J. B.; Rosenzweig, N.; Rosenzweig, Z. Superparamagnetic Fe2O3 Beads-CdSe/ZnS quantum dots core-shell nanocomposite particles for cell separation. Nano Lett., 2004, 4, 409-413.
41. Yi, D. K.; Selvan, S. T.; Lee, S. S.; Papaefthymiou, G. C.; Kundaliya, D.; Ying, J. Y. Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J. Am. Chem. Soc., 2005, 127, 4990-4991.
42. Sathe, T. R.; Agrawal, A.; Nie, S. M. Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: Dual-function microcarriers for optical encoding and magnetic separation. Anal. Chem., 2006, 78, 5627-5632.
43. Song, E. Q.; Wang, G. P.; Xie, H. Y.; Zhang, Z. L.; Hu, J.; Peng, J.; Wu, D. C.; Shi, Y. B.; Pang, D. W. Visual recognition and efficient isolation of apoptotic cells with a fluorescent-magnetic-biotargeting multifunctional nanospheres. Clin. Chem., 2007, 53, 2177-2185.
44. Kim, J.; Kim, H. S.; Lee, N.; Kim, T.; Kim, H.; Yu, T.; Song, I. C.; Moon, W. K.; Hyeon, T. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem., Int. Ed., 2008, 47, 8438-8441.
45. Louie, A. Multimodality imaging probes: design and challenges. Chem. Rev., 2010, 110, 3146-3195.
46. Al-Jamal, W. T.; Kostarelos, K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc. Chem. Res., 2011, 44, 1094-104.
47. Godin, B.; Tasciotti, E.; Liu, X. W.; Serda, R. E.; Ferrari, M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc. Chem. Res., 2011, 44, 979-989.
48. Fréchet, J. M. J.; Tomalia, D. A.; (Eds.) Dendrimers and Other Dendritic Polymers; Wiley-Blackwell, 2001.
49. Newkome, G. R.; Moorefield, C. N.; Vögtle, F. Dendrimers and Dendrons: Concepts, Syntheses, Applications; Wiley VCH, 2001.
50. Tomalia, D. A. Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog. Polym. Sci., 2005, 30, 294-324.
51. Boas, U.; Christensen, J. B.; Heegaard, P. M. H. Dendrimers in Medicine and Biotechnology: New Molecular Tools; RSC Publishing, 2006.
52. Najlah, M.; D'Emanuele, A. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery. Curr. Opin. Drug Discovery Dev., 2007, 10, 756-767.
53. Villalonga-Barber, C.; Micha-Screttas, M.; Steele, B. R.; Georgopoulos, A.; Demetzos, C. Dendrimers as biopharmaceuticals: Synthesis and properties. Curr. Top. Med. Chem., 2008, 8, 1294-1309.
54. Vögtle, F.; Gabriele, R.; Werner, N. Dendrimer Chemistry: Concepts, Syntheses, Properties, Applications; Wiley VCH, 2009.
55. Astruc, D.; Boisselier, E.; Ornelas, C. Dendrimers designed for functions: From physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. Chem. Rev., 2010, 110, 1857-1959.
56. Hourani, R.; Kakkar, A. Advances in the elegance of chemistry in designing dendrimers. Macromol. Rapid Commun., 2010, 31, 947-974.
57. Ottaviani, M. F.; Matteini, P.; Brustolon, M.; Turro, N. J.; Jockusch, S.; Tomalia, D. A. Characterization of starburst dendrimers and vesicle solutions and their interactions by CW- and pulsed-EPR, TEM, and dynamic light scattering. J. Phys. Chem. B, 1998, 102, 6029-6039.
58. Ottaviani, M. F.; Daddi, R.; Brustolon, M.; Turro, N. J.; Tomalia, D. A. Structural modifications of DMPC vesicles upon interaction with poly(amidoamine) dendrimers studied by CW-electron paramagnetic resonance and electron spin-echo techniques. Langmuir, 1999, 15, 1973-1980.
59. Ottaviani, M. F.; Favuzza, P.; Sacchi, B.; Turro, N. J.; Jockusch, S.; Tomalia, D. A. Interactions between starburst dendrimers and mixed DMPC/DMPANa vesicles studied by the spin label and the spin probe techniques, supported by transmission electron microscopy. Langmuir, 2002, 18, 2347-2357.
60. Purohit, G.; Sakthivel, T.; Florence, A. T. Interaction of cationic partial dendrimers with charged and neutral liposomes. Int. J. Pharm., 2001, 214, 71-76.
61. Zhang, Z.-Y.; Smith, B. D. High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: Membrane bending model. Bioconjugate Chem., 2000, 11, 805-814.
62. Mecke, A.; Uppuluri, S.; Sassanella, T. M.; Lee, D. K.; Ramamoorthy, A.; Baker, J. R.; Orr, B. G.; Holl, M. M. B. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem. Phys. Lipids, 2004, 132, 3-14.
63. Mecke, A.; Majoros, I. J.; Patri, A. K.; Baker, J. R.; Holl, M. M. B.; Orr, B. G. Lipid bilayer disruption by polycationic polymers: The roles of size and chemical functional group. Langmuir, 2005, 21, 10348-10354.
64. Hong, S. P.; Leroueil, P. R.; Janus, E. K.; Peters, J. L.; Kober, M. M.; Islam, M. T.; Orr, B. G.; Baker, J. R.; Holl, M. M. B. Interaction of polycationic polymers with supported lipid bilayers and cells: Nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chem., 2006, 17, 728-734.
65. Kelly, C. V.; Liroff, M. G.; Triplett, L. D.; Leroueil, P. R.; Mullen, D. G.; Wallace, J. M.; Meshinchi, S.; Baker, J. R.; Orr, B. G.; Holl, M. M. B. Stoichiometry and structure of poly(amidoamine) dendrimer-lipid complexes. ACS Nano, 2009, 3, 1886-1896.
66. Karoonuthaisiri, N.; Titiyevskiy, K.; Thomas, J. L. Destabilization of fatty acid-containing liposomes by. polyamidoamine dendrimers. Colloids Surf. B, 2003, 27, 365-375.
67. Shcharbin, D.; Drapeza, A.; Loban, V.; Lisichenok, A.; Bryszewska, M. The breakdown of bilayer lipid membranes by dendrimers. Cell. Mol. Biol. Lett., 2006, 11, 242-248.
68. Klajnert, B.; Epand, R. M. PAMAM dendrimers and model membranes: Differential scanning calorimetry studies. Int. J. Pharm. 2005, 305, 154-166.
69. Gardikis, K.; Hatziantoniou, S.; Viras, K.; Wagner, M.; Demetzos, C. A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes. Int. J. Pharm., 2006, 318, 118-123.
70. Ainalem, M. L.; Campbell, R. A.; Khalid, S.; Gillams, R. J.; Rennie, A. R.; Nylander, T. On the ability of PAMAM dendrimers and dendrimer/DNA aggregates to penetrate POPC model biomembranes. J. Phys. Chem. B, 2010, 114, 7229-7244.
71. Akesson, A.; Bendtsen, K. M.; Beherens, M. A.; Pedersen, J. S.; Alfredsson, V.; Gomez, M. C. The effect of PAMAM G6 dendrimers on the structure of lipid vesicles. Phys. Chem. Chem. Phys., 2010, 12, 12267-12272.
72. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials, 2003, 24, 1121-1131.
73. Ionov, M.; Gardikis, K.; Wrobel, D.; Hatziantoniou, S.; Mourelatou, H.; Majoral, J. P.; Klajnert, B.; Bryszewska, M.; Demetzos, C. Interaction of cationic phosphorus dendrimers (CPD) with charged and neutral lipid membranes. Colloids Surf. B, 2011, 82, 8-12.
74. Gregoriadis, G. Engineering liposomes for drug delivery: Progress and problems. Trends Biotechnol., 1995, 13, 527-537.
75. Abraham, S. A.; Waterhouse, D. N.; Mayer, L. D.; Cullis, P. R.; Madden, T. D.; Bally, M. B. The liposomal formulation of doxorubicin. In Methods in Enzymology; 2005; Vol. 391, pp. 71-97.
76. Zhang, L.; Gu, F. X.; Chan, J. M.; Wang, A. Z.; Langer, R. S.; Farokhzad, O. C. Nanoparticles in medicine: Therapeutic applications and developments. Clin. Pharmacol. Therap., 2008, 83, 761-769.
77. Schiffelers, R. M.; Storm, G. Liposomal nanomedicines as anticancer therapeutics: Beyond targeting tumor cells. Int. J. Pharm., 2008, 364, 258-264.
78. Miyajima, K. Role of saccharides for the freeze-thawing and freeze drying of liposome. Adv. Drug Delivery Rev., 1997, 24, 151-159.
79. Hatziantoniou, S.; Dimas, K.; Georgopoulos, A.; Sotiriadou, N.; Demetzos, C. Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol. Res., 2006, 53, 80-87.
80. Chen, C. J.; Han, D. D.; Cai, C. F.; Tang, X. An overview of liposome lyophilization and its future potential. J. Controlled Release, 2010, 142, 299-311.
81. Drummond, D. C.; Meyer, O.; Hong, K. L.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev., 1999, 51, 691-743.
82. Charrois, G. J. R.; Allen, T. M. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim. Biophys. Acta, Biomembr., 2004, 1663, 167-177.
83. Sarbolouki, M. N.; Sadeghizadeh, M.; Yaghoobi, M. M.; Karami, A.; Lohrasbi, T. Dendrosomes: a novel family of vehicles for transfection and therapy. J. Chem. Technol. Biotechnol., 2000, 75, 919-922.
84. Sadeghizadeh, M.; Ranjbar, B.; Damaghi, M.; Khaki, L.; Sarbolouki, M. N.; Najafi, F.; Parsaee, S.; Ziaee, A.-A.; Massumi, M.; Lubitz, W.; Kudela, P.; Paukner, S.; Karami, A. Dendrosomes as novel gene porters-III. J. Chem. Technol. Biotechnol., 2008, 83, 912-920.
85. Movassaghian, S.; Moghimi, H. R.; Shirazi, F. H.; Torchilin, V. P. Dendrosome-dendriplex inside liposomes: as a gene delivery system. J. Drug Targeting, 2011, 19, 925-932.
86. Khopade, A. J.; Caruso, F. Stepwise self-assembled poly(amidoamine) dendrimer and poly(styrenesulfonate) microcapsules as sustained delivery vehicles. Biomacromolecules, 2002, 3, 1154-1162.
87. Moraes, M. L.; Baptista, M. S.; Itri, R.; Zucolotto, V.; Oliveira, O. N. Immobilization of liposomes in nanostructured layer-by-layer films containing dendrimers. Mater. Sci. Eng. C, 2008, 28, 467-471.
88. Geraldo, V. P. N.; Moraes, M. L.; Zucolotto, V.; Oliveira, O. N. Immobilization of ibuprofen-containing nanospheres in layer-by-layer films. J. Nanosci. Nanotechnol., 2011, 11, 1167-1174.
89. Gardikis, K.; Hatziantoniou, S.; Bucos, M.; Fessas, D.; Signorelli, M.; Felekis, T.; Zervou, M.; Screttas, C. G.; Steele, B. R.; Ionov, M.; Micha-Screttas, M.; Klajnert, B.; Bryszewska, M.; Demetzos, C. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. J. Pharm. Sci., 2010, 99, 3561-3571.
90. Gardikis, K.; Hatziantoniou, S.; Signorelli, M.; Pusceddu, M.; Micha-Screttas, M.; Schiraldi, A.; Demetzos, C.; Fessas, D. Thermodynamic and structural characterization of liposomal-locked in-dendrimers as drug carriers. Colloids Surf. B, 2010, 81, 11-19.
91. Gardikis, K.; Tsimplouli, C.; Dimas, K.; Micha-Screttas, M.; Demetzos, C. New chimeric advanced drug delivery nano systems (chi-aDDnSs) as doxorubicin carriers. Int. J. Pharm., 2010, 402, 231-237.
92. Khopade, A. J.; Caruso, F.; Tripathi, P.; Nagaich, S.; Jain, N. K. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int. J. Pharm., 2002, 232, 157-162.
93. Papagiannaros, A.; Demetzos, C.; Dimas, K.; Papaioannou, G. T. In vitro cytotoxic activity of doxorubicin-PAMAM Dendrimer complex incorporated into HePC liposomes against cancer cell lines. Anticancer Res., 2004, 24, 386.
94. Papagiannaros, A.; Dimas, K.; Papaioannou, G. T.; Demetzos, C. Doxorubicin-PAMAM dendrimer complex attached to liposomes: Cytotoxic studies against human cancer cell lines. Int. J. Pharm., 2005, 302, 29-38.
95. Hupfeld, S.; Moen, H. H.; Ausbacher, D.; Haas, H.; Brandl, M. Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: influence of ionic strength and osmotic pressure of the carrier liquid. Chem. Phys. Lipids, 2010, 163, 141-147.
96. Gardikis, K.; Fessas, D.; Signorelli, M.; Dimas, K.; Tsimplouli, C.; Ionov, M.; Demetzos, C. A new chimeric drug delivery nano system (chi-aDDnS) composed of PAMAM G 3.5 dendrimer and liposomes as doxorubicin's carrier. In vitro pharmacological studies. J. Nanosci. Nanotechnol., 2011, 11, 3764-3772.
97. Ohori, R.; Uchida, K.; Saito, A.; Yajima, H. Poly(ethylene glycol)-mediated steric stabilization of complexes formed between negatively charged liposomes and folate-conjugated poly(amidoamine) dendrimers in water. Chem. Lett., 2008, 37, 324-325.
98. Liu, Y.; Sun, K. X.; Yao, W. J.; Liang, N.; Mu, H. J.; Liang, R. C.; Yao, C. Preparation, characterization of PAMAM dendrimers-coated liposomes and evaluation for ophthalmic drug delivery. Chem. J. Chin. U., 2010, 31, 800-805.
99. Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev., 1999, 99, 2293-2352.
100. Su, M. Y.; Muhler, A.; Lao, X. Y.; Nalcioglu, O. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn. Reson. Med., 1998, 39, 259-269.
101. Bogdanov, A. A.; Weissleder, R.; Brady, T. J. Long-circulating blood pool imaging agents. Adv. Drug Delivery Rev., 1995, 16, 335-348.
102. Langereis, S.; Dirksen, A.; Hackeng, T. M.; van Genderen, M. H. P.; Meijer, E. W. Dendrimers and magnetic resonance imaging. New J. Chem., 2007, 31, 1152-1160.
103. Cheng, Z. L.; Tsourkas, A. Paramagnetic porous polymersomes. Langmuir, 2008, 24, 8169-8173.
104. Longmire, M.; Choyke, P. L.; Kobayashi, H. Dendrimer-based contrast agents for molecular imaging. Curr. Top. Med. Chem., 2008, 8, 1180-1186.
105. Castelli, D. D.; Gianolio, E.; Crich, S. G.; Terreno, E.; Aime, S. Metal containing nanosized systems for MR-molecular imaging applications. Coord. Chem. Rev., 2008, 252, 2424-2443.
106. Accardo, A.; Tesauro, D.; Aloj, L.; Pedone, C.; Morelli, G. Supramolecular aggregates containing lipophilic Gd(III) complexes as contrast agents in MRI. Coord. Chem. Rev., 2009, 253, 2193-2213.
107. Moriggi, L.; Cannizzo, C.; Dumas, E.; Mayer, C. R.; Ulianov, A.; Helm, L. Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents. J. Am. Chem. Soc., 2009, 131, 10828-10829.
108. Mody, V. V.; Nounou, M. I.; Bikram, M. Novel nanomedicine-based MRI contrast agents for gynecological malignancies. Adv. Drug Delivery Rev., 2009, 61, 795-807.
109. Siddiqui, T. S.; Jani, A.; Williams, F.; Muller, R. N.; Elst, L.; Laurent, S.; Yao, F.; Wadghiri, Y. Z.; Walters, M. A. Lanthanide complexes on Ag nanoparticles: Designing contrast agents for magnetic resonance imaging. J. Colloid Interface Sci., 2009, 337, 88-96.
110. Ogawa, M.; Regino, C. A. S.; Marcelino, B.; Williams, M.; Kosaka, N.; Bryant, L. H.; Choyke, P. L.; Kobayashi, H. New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules. Bioconjugate Chem., 2010, 21, 955-960.
111. Stollenwerk, M. M.; Pashkunova-Martic, I.; Kremser, C.; Talasz, H.; Thurner, G. C.; Abdelmoez, A. A.; Wallnofer, E. A.; Helbok, A.; Neuhauser, E.; Klammsteiner, N.; Klimaschewski, L.; von Guggenberg, E.; Frohlich, E.; Keppler, B.; Jaschke, W.; Debbage, P. Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation. Histochem. Cell Biol., 2010, 133, 375-404.
112. Abdelmoez, A. A.; Thurner, G. C.; Wallnöfer, E. A.; Klammsteiner, N.; Kremser, C.; Talasz, H.; Mrakovcic, M.; Fröhlich, E.; Jaschke, W.; Debbage, P. Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles. Histochem. Cell Biol., 2010, 134, 171-96.
113. Villaraza, A. J. L.; Bumb, A.; Brechbiel, M. W. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: The interplay between size, function, and pharmacokinetics. Chem. Rev., 2010, 110, 2921-2959.
114. Della Rocca, J.; Lin, W. B. Nanoscale metal-organic frameworks: Magnetic resonance imaging contrast agents and beyond. Eur. J. Inorg. Chem., 2010, 3725-3734.
115. Ghaghada, K. B.; Colen, R. R.; Hawley, C. R.; Patel, N.; Mukundan, S. Liposomal contrast agents in brain tumor imaging. Neuroimag. Clin. N. Am., 2010, 20, 367-+.
116. Kamaly, N.; Miller, A. D. Paramagnetic liposome nanoparticles for cellular and tumour imaging. Int. J. Mol. Sci., 2010, 11, 1759-1776.
117. Steinmetz, N. F. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomed.-Nanotechnol., 2010, 6, 634-641.
118. Rosenberg, J. T.; Kogot, J. M.; Lovingood, D. D.; Strouse, G. F.; Grant, S. C. Intracellular bimodal nanoparticles based on quantum dots for high-field MRI at 21.1 T. Magn. Reson. Med., 2010, 64, 871-882.
119. Park, J. A.; Kim, H. K.; Kim, J. H.; Jeong, S. W.; Jung, J. C.; Lee, G. H.; Lee, J.; Chang, Y.; Kim, T. J. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg. Med. Chem. Lett., 2010, 20, 2287-2291.
120. Cheng, Z. L.; Thorek, D. L. J.; Tsourkas, A. Porous polymersomes with encapsulated Gd-labeled dendrimers as highly efficient MRI contrast agents. Adv. Funct. Mater., 2009, 19, 3753-3759.
121. Bianco, A.; Kostarelos, K.; Prato, M. Applications of carbon nanotubes in drug delivery. Curr. Opin. Chem. Biol., 2005, 9, 674-679.
122. Kostarelos, K.; Bianco, A.; Prato, M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nature Nanotechnol., 2009, 4, 627-633.
123. Liu, Z.; Tabakman, S.; Welsher, K.; Dai, H. J. Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res., 2009, 2, 85-120.
124. Aschberger, K.; Johnston, H. J.; Stone, V.; Aitken, R. J.; Hankin, S. M.; Peters, S. A. K.; Tran, C. L.; Christensen, F. M. Review of carbon nanotubes toxicity and exposure-Appraisal of human health risk assessment based on open literature. Crit. Rev. Toxicol., 2010, 40, 759-790.
125. Firme III, C. P.; Bandaru, P. R. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomed.-Nanotechnol., 2010, 6, 245-256.
126. Woo, S.; Lee, Y.; Sunkara, V.; Cheedarala, R. K.; Shin, H. S.; Choi, H. C.; Park, J. W. "Fingertip"-Guided noncovalent functionalization of carbon nanotubes by dendrons. Langmuir, 2007, 23, 11373-11376.
127. Shen, M. W.; Wang, S. H.; Shi, X. Y.; Chen, X. S.; Huang, Q. G.; Petersen, E. J.; Pinto, R. A.; Baker, J. R.; Weber, W. J. Polyethyleneimine- mediated functionalization of multiwalled carbon nanotubes: synthesis, characterization, and in vitro toxicity assay. J. Phys. Chem. C, 2009, 113, 3150-3156.
128. Karousis, N.; Tagmatarchis, N.; Tasis, D. Current progress on the chemical modification of carbon nanotubes. Chem. Rev., 2010, 110, 5366-97.
129. Zhang, B. L.; Chen, Q. O.; Tang, H.; Xie, Q. J.; Ma, M.; Tan, L. A.; Zhang, Y. Y.; Yao, S. Z. Characterization of and biomolecule immobilization on the biocompatible multi-walled carbon nanotubes generated by functionalization with polyamidoamine dendrimers. Colloids Surf. B, 2010, 80, 18-25.
130. Caminade, A.-M.; Majoral, J.-P. Dendrimers and nanotubes: a fruitful association. Chem. Soc. Rev., 2010, 39, 2034-2047.
131. Pan, B. F.; Cui, D. X.; Gao, F.; He, R. Growth of multi-amine terminated poly(amidoamine) dendrimers on the surface of carbon nanotubes. Nanotechnology, 2006, 17, 2483-2489.
132. Pan, B. F.; Cui, D. X.; Xu, P.; Ozkan, C.; Feng, G.; Ozkan, M.; Huang, T.; Chu, B. F.; Li, Q.; He, R.; Hu, G. H. Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology, 2009, 20, 125101.
133. Herrero, M. A.; Toma, F. M.; Al-Jamal, K. T.; Kostarelos, K.; Bianco, A.; Da Ros, T.; Bano, F.; Casalis, L.; Scoles, G.; Prato, M. Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery. J. Am. Chem. Soc., 2009, 131, 9843-9848.
134. Al-Jamal, K. T.; Toma, F. M.; Yilmazer, A.; Ali-Boucetta, H.; Nunes, A.; Herrero, M. A.; Tian, B.; Eddaoui, A.; Al-Jamal, W. T.; Bianco, A.; Prato, M.; Kostarelos, K. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes. FASEB J., 2010, 24, 4354-4365.
135. Guo, C.; Al-Jamal, K. T.; Bianco, A.; Prato, M.; Kostarelos, K. Carbon nanotube-dendron series for siRNA delivery: mechanisms of cellular internalisation. Drug Discov. Today, 2010, 15, A56.
136. Yang, K. Q.; Qin, W. L.; Tang, H.; Tan, L.; Xie, Q. J.; Ma, M.; Zhang, Y. Y.; Yao, S. Z. Polyamidoamine dendrimer-functionalized carbon nanotubesmediated GFP gene transfection for HeLa cells: Effects of different types of carbon nanotubes. J. Biomed. Mater. Res. Part A, 2011, 99A, 231-239.
137. McCarroll, J.; Baigude, H.; Yang, C. S.; Rana, T. M. Nanotubes functionalized with lipids and natural amino acid dendrimers: A new strategy to create nanomaterials for delivering systemic RNAi. Bioconjugate Chem., 2010, 21, 56-63.
138. Sobhani, Z.; Dinarvand, R.; Atyabi, F.; Ghahremani, M.; Adeli, M. Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube. Int. J. Nanomed., 2011, 6, 705-719.
139. Zeng, Y. L.; Tang, C. R.; Wang, H. W.; Jiang, J. H.; Tian, M. N.; Shen, G. L.; Yu, R. Q. A novel density-tunable nanocomposites of CdTe quantum dots linked to dendrimer-tethered multi-wall carbon nanotubes. Spectrochim. Acta Part A, 2008, 70, 966-972.
140. Adeli, M.; Hakimpoor, F.; Ashiri, M.; Kabiri, R.; Bavadi, M. Anticancer drug delivery systems based on noncovalent interactions between carbon nanotubes and linear-dendritic copolymers. Soft Matter, 2011, 7, 4062-4070.
141. Mehdipoor, E.; Adeli, M.; Bavadi, M.; Sasanpour, P.; Rashidian, B. A possible anticancer drug delivery system based on carbon nanotube-dendrimer hybrid nanomaterials. J. Mater. Chem., 2011, 21, 15456-15463.
142. Zhang, Y. Y.; Qin, W. L.; Tang, H.; Yan, F.; Tan, L.; Xie, Q. J.; Ma, M.; Yao, S. Z. Efficient assembly of multi-walled carbon nanotube-CdSe/ZnS quantum dot hybrids with high biocompatibility and fluorescence property. Colloids Surf. B, 2011, 87, 346-352.
143. Zhu, H. Y.; Zhu, Y. H.; Yang, X. L.; Li, C. Z. Multiwalled carbon nanotubes incorporated with dendrimer encapsulated with Pt nanoparticles: An attractive material for sensitive biosensors. Chem. Lett., 2006, 35, 326-327.
144. Zeng, Y.-L.; Huang, Y.-F.; Jiang, J.-H.; Zhang, X.-B.; Tang, C.-R.; Shen, G.- L.; Yu, R.-Q. Functionalization of multi-walled carbon nanotubes with poly(amidoamine) dendrimer for mediator-free glucose biosensor. Electrochem. Commun., 2007, 9, 185-190.
145. Xu, L.; Zhu, Y.; Yang, X.; Li, C. Amperometric biosensor based on carbon nanotubes coated with polyaniline/dendrimer-encapsulated Pt nanoparticles for glucose detection. Mater. Sci. Eng. C, 2009, 29, 1306-1310.
146. Tang, L. H.; Zhu, Y. H.; Xu, L. H.; Yang, X. L.; Li, C. Z. Amperometric glutamate biosensor based on self-assembling glutamate dehydrogenase and dendrimer-encapsulated platinum. nanoparticles onto carbon nanotubes. Talanta, 2007, 73, 438-443.
147. Siqueira, J. R.; Abouzar, M. H.; Poghossian, A.; Zucolotto, V.; Oliveira, O. N.; Schoning, M. J. Penicillin biosensor based on a capacitive field-effect structure functionalized with a dendrimer/carbon nanotube multilayer. Biosens. Bioelectron., 2009, 25, 497-501.
148. Zhu, N. N.; Gao, H.; Xua, Q.; Lin, Y. G.; Su, L.; Mao, L. Q. Sensitive impedimetric DNA biosensor with poly(amidoamine) dendrimer covalently attached onto carbon nanotube electronic transducers as the tether for surface confinement of probe DNA. Biosens. Bioelectron., 2010, 25, 1498-1503.
149. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Elst, L. V.; Muller, R. N. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev., 2008, 108, 2064-2110.
150. Lamanna, G.; Kueny-Stotz, M.; Mamlouk-Chaouachi, H.; Ghobril, C.; Basly, B.; Bertin, A.; Miladi, I.; Billotey, C.; Pourroy, G.; Begin-Colin, S.; Felder-Flesch, D. Dendronized iron oxide nanoparticles for multimodal imaging. Biomaterials, 2011, 32, 8562-8573.
151. Chandra, S.; Mehta, S.; Nigam, S.; Bahadur, D. Dendritic magnetite nanocarriers for drug delivery applications. New J. Chem., 2010, 34, 648-655.
152. Chang, Y. L.; Meng, X. L.; Zhao, Y. L.; Li, K.; Zhao, B.; Zhu, M.; Li, Y. P.; Chen, X. S.; Wang, J. Y. Novel water-soluble and pH-responsive anticancer drug nanocarriers: Doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). J. Colloid Interface Sci., 2011, 363, 403-9.
153. Saboktakin, M. R.; Maharramov, A.; Ramazanov, M. A. Synthesis and characterization of MRI-detectable magnetic dendritic nanocarriers. Polym.-Plast. Technol. Eng., 2010, 49, 104-109.
154. Pan, B. F.; Cui, D. X.; Sheng, Y.; Ozkan, C. G.; Gao, F.; He, R.; Li, Q.; Xu, P.; Huang, T. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res., 2007, 67, 8156-8163.
155. Taratula, O.; Garbuzenko, O.; Savla, R.; Wang, Y. A.; He, H. X.; Minko, T. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr. Drug Delivery, 2011, 8, 59-69.
156. Wang, H.; Zheng, L. F.; Peng, C.; Guo, R.; Shen, M. W.; Shi, X. Y.; Zhang, G. X. Computed tomography imaging of cancer cells using acetylated dendrimer- entrapped gold nanoparticles. Biomaterials, 2011, 32, 2979-2988.
157. Llevot, A.; Astruc, D. Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer. Chem. Soc. Rev., 2012, 41, 242-257.
158. Daniel, M. C.; Astruc, D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev., 2004, 104, 293-346.
159. Hu, M.; Chen, J. Y.; Li, Z. Y.; Au, L.; Hartland, G. V.; Li, X. D.; Marquez, M.; Xia, Y. N. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev., 2006, 35, 1084-1094.
160. Paasonen, L.; Laaksonen, T.; Johans, C.; Yliperttula, M.; Kontturi, K.; Urth, A. Gold nanoparticles enable selective light-induced contents release from liposomes. J. Controlled Release, 2007, 122, 86-93.
161. Kojima, C.; Toi, Y.; Harada, A.; Kono, K. Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy. Bioconjugate Chem., 2007, 18, 663-670.
162. Haba, Y.; Kojima, C.; Harada, A.; Ura, T.; Horinaka, H.; Kono, K. Preparation of poly(ethylene glycol)-modified poly(amido amine) dendrimers encapsulating gold nanoparticles and their heat-generating ability. Langmuir, 2007, 23, 5243-5246.
163. Kojima, C.; Hirano, Y.; Yuba, E.; Harada, A.; Kono, K. Preparation and characterization of complexes of liposomes with gold nanoparticles. Colloids Surf. B, 2008, 66, 246-252.
164. Paasonen, L.; Sipila, T.; Subrizi, A.; Laurinmaki, P.; Butcher, S. J.; Rappolt, M.; Yaghmur, A.; Urtti, A.; Yliperttula, M. Gold-embedded photosensitive liposomes for drug delivery: Triggering mechanism and intracellular release. J. Controlled Release, 2010, 147, 136-143.
165. Umeda, Y.; Kojima, C.; Harada, A.; Horinaka, H.; Kono, K. PEG-Attached PAMAM dendrimers encapsulating gold nanoparticles: Growing gold nanoparticles in the dendrimers for improvement of their photothermal properties. Bioconjugate Chem., 2010, 21, 1559-1564.
166. Esumi, K.; Suzuki, A.; Aihara, N.; Usui, K.; Torigoe, K. Preparation of gold colloids with UV irradiation using dendrimers as stabilizer. Langmuir, 1998, 14, 3157-3159.
167. Grohn, F.; Bauer, B. J.; Akpalu, Y. A.; Jackson, C. L.; Amis, E. J. Dendrimer templates for the formation of gold nanoclusters. Macromolecules, 2000, 33, 6042-6050.
168. Lin, C. A. J.; Lee, C. H.; Hsieh, J. T.; Wang, H. H.; Li, J. K.; Shen, J. L.; Chan, W. H.; Yeh, H. I.; Chang, W. H. Synthesis of fluorescent metallic nanoclusters toward biomedical application: Recent progress and present challenges. J. Med. Biol. Eng., 2009, 29, 276-283.
169. Murugan, E.; Vimala, G. Effective functionalization of multiwalled carbon nanotube with amphiphilic poly(propyleneimine) dendrimer carrying silver nanoparticles for better dispersability and antimicrobial activity. J. Colloid Interface Sci., 2011, 357, 354-365.
170. Neelgund, G. M.; Oki, A. Deposition of silver nanoparticles on dendrimer functionalized multiwalled carbon nanotubes: Synthesis, characterization and antimicrobial activity. J. Nanosci. Nanotechnol., 2011, 11, 3621-3629.
171. Oh, S. K.; Kim, Y. G.; Ye, H. C.; Crooks, R. M. Synthesis, characterization, and surface immobilization of metal nanoparticles encapsulated within bifunctionalized dendrimers. Langmuir, 2003, 19, 10420-10425.
172. Hong, C. Y.; Yamauchi, Y.; Wu, K. C. W. In vitro cytotoxicity and intracellular bioimaging of dendritic platinum nanoparticles by differential interference contrast (DIC). Chem. Lett., 2011, 40, 408-409.
173. Shao, L.; Gao, Y.; Yan, F. Semiconductor Quantum Dots for Biomedicial Applications. Sensors, 2011, 11, 11736-11751.
174. Jin, S.; Hu, Y.; Gu, Z.; Liu, L.; Wu, H.-C. Application of Quantum Dots in Biological Imaging. J. Nanomater., 2011, 1-13.
175. Tavares, A. J.; Chong, L.; Petryayeva, E.; Algar, W. R.; Krull, U. J. Quantum dots as contrast agents for in vivo tumor imaging: progress and issues. Anal. Bioanal. Chem., 2011, 399, 2331-42.
176. Luo, G.; Long, J.; Zhang, B.; Liu, C.; Ji, S.; Xu, J.; Yu, X.; Ni, Q. Quantum dots in cancer therapy. Expert Opin. Drug. Deliv., 2012, 9, 47-58.
177. Sooklal, K.; Huang, J.; Murphy, C. J.; Hanus, L.; Ploehn, H. J. Inorganic quantum dot-organic dendrimer nanocomposite materials. In Organic/Inorganic Hybrid Materials II; Klein, LC and Francis, LF and DeGuire, MR and Mark, J., Ed.; 1999; Vol. 576, pp. 439-444.
178. Guo, W. Z.; Li, J. J.; Wang, Y. A.; Peng, X. G. Conjugation chemistry and bioapplications of semiconductor box nanocrystals prepared via dendrimer bridging. Chem. Mater., 2003, 15, 3125-3133.
179. Cong, R. M.; Luo, Y. J.; Li, G. P.; Tan, H. M. In-situ synthesis of CdS-ZnS core-shell structure quantum dots inside PAMAM dendrimer templates. Chem. J. Chin. U., 2006, 27, 793-796.
180. Adeli, M.; Sarabi, R. S.; Sadeghi, E. Hybrid nanomaterials containing PAMAM, polyrotaxane and quantum dot blocks. Nano, 2011, 6, 239.
181. Mohs, A. M.; Duan, H. W.; Kairdolf, B. A.; Smith, A. M.; Nie, S. M. Protonresistant quantum dots: Stability in gastrointestinal fluids and implications for oral delivery of nanoparticle agents. Nano Res., 2009, 2, 500-508.
182. Bakalova, R.; Zhelev, Z.; Kokuryo, D.; Spasov, L.; Aoki, I.; Saga, T. Chemical nature and structure of organic coating of quantum dots is crucial for their application in imaging diagnostics. Int. J. Nanomed., 2011, 6, 1719-32.
183. Zhao, Y. L.; Liu, S.; Li, Y. P.; Jiang, W.; Chang, Y. L.; Pan, S.; Fang, X. X.; Wang, Y. A.; Wang, J. Y. Synthesis and grafting of folate-PEG-PAMAM conjugates onto quantum dots for selective targeting of folate-receptorpositive tumor cells. J. Colloid Interface Sci., 2010, 350, 44-50.
184. Duan, H. W.; Nie, S. M. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J. Am. Chem. Soc., 2007, 129, 3333-3338.
185. Li, Z. M.; Huang, P.; He, R.; Lin, J.; Yang, S.; Zhang, X. J.; Ren, Q. S.; Cui, D. X. Aptamer-conjugated dendrimer-modified quantum dots for cancer cell targeting and imaging. Mater. Lett., 2010, 64, 375-378.
186. Li, Z. M.; Huang, P.; Lin, J.; He, R.; Liu, B.; Zhang, X. M.; Yang, S.; Xi, P.; Zhang, X. J.; Ren, Q. S.; Cui, D. X. Arginine-glycine-aspartic acidconjugated dendrimer-modified quantum dots for targeting and imaging melanoma. J. Nanosci. Nanotechnol., 2010, 10, 4859-4867.
187. Geraldo, D. A.; Duran-Lara, E. F.; Aguayo, D.; Cachau, R. E.; Tapia, J.; Esparza, R.; Yacaman, M. J.; Gonzalez-Nilo, F. D.; Santos, L. S. Supramolecular complexes of quantum dots and a polyamidoamine (PAMAM)-folate derivative for molecular imaging of cancer cells. Anal. Bioanal. Chem., 2011, 400, 483-492.
188. Higuchi, Y.; Wu, C.; Chang, K. L.; Irie, K.; Kawakami, S.; Yamashita, F.; Hashida, M. Polyamidoamine dendrimer-conjugated quantum dots for efficient labeling of primary cultured mesenchymal stem cells. Biomaterials, 2011, 32, 6676-6682.
189. Feng, C. L.; Yu, Y. M.; Zhong, X. H.; Steinhart, M.; Majoral, J. P.; Knoll, W. Quantum-dot/dendrimer based functional nanotubes for sensitive detection of DNA hybridization. In Advances in Science and Technology: Smart Optics; Vincenzini, P.; Righini, G., Eds.; 2009; Vol. 55, pp. 84-90.
190. Zhou, D.; Li, Y.; Hall, E. A. H.; Abell, C.; Klenerman, D. A chelating dendritic ligand capped quantum dot: preparation, surface passivation, bioconjugation and specific DNA detection. Nanoscale, 2011, 3, 201-211.
191. Triulzi, R. C.; Micic, M.; Giordani, S.; Serry, M.; Chiou, W.-A.; Leblanc, R. M. Immunoasssay based on the antibody-conjugated PAMAM-dendrimergold quantum dot complex. Chem. Commun., 2006, 5068-5070.
192. Triulzi, R. C.; Micic, M.; Orbulescu, J.; Giordani, S.; Mueller, B.; Leblanc, R. M. Antibody gold quantum dot PAMAM dendrimer complex as an immunoglobulin immunoassay. Analyst, 2008, 133, 667-672.
193. Ghosh, S.; Ghosh, D.; Bag, P. K.; Bhattacharya, S. C.; Saha, A. Aqueous synthesis of ZnTe/dendrimer nanocomposites and their antimicrobial activity: implications in therapeutics. Nanoscale, 2011, 3, 1139-1148.
194. Nishiyama, N.; Stapert, H. R.; Zhang, G. D.; Takasu, D.; Jiang, D. L.; Nagano, T.; Aida, T.; Kataoka, K. Light-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapy. Bioconjugate Chem., 2003, 14, 58-66.
195. Zhang, G. D.; Nishiyama, N.; Harada, A.; Jiang, D. L.; Aida, T.; Kataoka, K. pH-sensitive assembly of light-harvesting dendrimer zinc porphyrin bearing peripheral groups of primary amine with poly(ethylene glycol)-bpoly(aspartic acid) in aqueous solution. Macromolecules, 2003, 36, 1304-1309.
196. Battah, S.; Balaratnam, S.; Casas, A.; O'Neill, S.; Edwards, C.; Batlle, A.; Dobbin, P.; MacRobert, A. J. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol. Cancer Ther. 2007, 6, 876-85.
197. Majoros, I. J.; Williams, C. R.; Baker, J. R. Current dendrimer applications in cancer diagnosis and therapy. Curr. Top. Med. Chem., 2008, 8, 1165-1179.
198. Casas, A.; Battah, S.; Di Venosa, G.; Dobbin, P.; Rodriguez, L.; Fukuda, H.; Batlle, A.; MacRobert, A. J. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy. J. Controlled Release, 2009, 135, 136-143.
199. Nishiyama, N.; Morimoto, Y.; Jang, W. D.; Kataoka, K. Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv. Drug Delivery Rev., 2009, 61, 327-338.
200. Ideta, R.; Tasaka, F.; Jang, W. D.; Nishiyama, N.; Zhang, G. D.; Harada, A.; Yanagi, Y.; Tamaki, Y.; Aida, T.; Kataoka, K. Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett., 2005, 5, 2426-2431.
201. Jang, W. D.; Nishiyama, N.; Zhang, G. D.; Harada, A.; Jiang, D. L.; Kawauchi, S.; Morimoto, Y.; Kikuchi, M.; Koyama, H.; Aida, T.; Kataoka, K. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. Angew. Chem. Int. Ed., 2005, 44, 419-423.
202. Jang, W. D.; Nakagishi, Y.; Nishiyama, N.; Kawauchi, S.; Morimoto, Y.; Kikuchi, M.; Kataoka, K. Polyion complex micelles for photodynamic therapy: Incorporation of dendritic photosensitizer excitable at long wavelength relevant to improved tissue-penetrating property. J. Controlled Release, 2006, 113, 73-79.
203. Jang, W. D.; Nishiyama, N.; Kataoka, K. Preparation of naphthalocyanine dendrimer loaded polyion complex micelle for photodynamic therapy. In ASBM7: Advanced Biomaterials VII Book Series: Key Engineering Materials, Volume: 342-343; Kim, Y. H.; Cho, C. S.; Kang, I. K.; Kim, S. Y.; Kwon, O. H., Eds.; 2007; Vol. 342-343, pp. 465-468.
204. Nishiyama, N.; Jang, W.-D.; Kataoka, K. Supramolecular nanocarriers integrated with dendrimers encapsulating photosensitizers for effective photodynamic therapy and photochemical gene delivery. New J. Chem., 2007, 31, 1074-1082.
205. Sugisaki, K.; Usui, T.; Nishiyama, N.; Jang, W. D.; Yanagi, Y.; Yamagami, S.; Amano, S.; Kataoka, K. Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins. Invest. Ophth. Vis. Sci., 2008, 49, 894-899.
206. Nishiyama, N.; Nakagishi, Y.; Morimoto, Y.; Lai, P. S.; Miyazaki, K.; Urano, K.; Horie, S.; Kumagai, M.; Fukushima, S.; Cheng, Y.; Jang, W. D.; Kikuchi, M.; Kataoka, K. Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. J. Controlled Release, 2009, 133, 245-251.
207. Nishiyama, N.; Arnida; Jang, W. D.; Date, K.; Miyata, K.; Kataoka, K. Photochemical enhancement of transgene expression by polymeric micelles incorporating plasmid DNA and dendrimer-based photosensitizer. J. Drug Targeting, 2006, 14, 413-424.
208. Arnida; Nishiyama, N.; Kanayama, N.; Jang, W. D.; Yamasaki, Y.; Kataoka, K. PEGylated gene nanocarriers based on block catiomers bearing ethylenediamine repeating units directed to remarkable enhancement of photochemical transfection. J. Controlled Release, 2006, 115, 208-215.